Skip to main content

#153651

Anti-Growth Differentiation Factor 9 [53/1]

Cat. #153651

Anti-Growth Differentiation Factor 9 [53/1]

Cat. #: 153651

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Growth Differentiation Factor 9

Class: Monoclonal

Application: ELISA ; IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: BioServ UK Ltd

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Growth Differentiation Factor 9 [53/1]
  • Alternate name: Growth/differentiation factor 9, GDF-9, GDF9
  • Research fields: Cell signaling and signal transduction
  • Clone: 53/1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 17.5 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IHC ; WB
  • Description: GDF9 is plays a vital role in ovarian folliculogenesis, follicle development and fertility. Clone 53/1 can be used in assays to detect oocyte expression and has been shown to neutralize GDF9 biological activity.
  • Immunogen: Tuberculin coupled peptide with sequence VPAKYSPLSVLTIEPDGSIAYKEYEDMIATKC that recognizes an epitope with the EPDG sequence near the C-terminal region of human GDF9
  • Isotype: IgG1
  • Myeloma used: Sp2/0-Ag14
  • Recommended controls: Ovary

Target Details

  • Target: Growth Differentiation Factor 9
  • Molecular weight: 17.5 kDa
  • Tissue cell line specificity: Ovary
  • Target background: GDF9 is plays a vital role in ovarian folliculogenesis, follicle development and fertility. Clone 53/1 can be used in assays to detect oocyte expression and has been shown to neutralize GDF9 biological activity.

Applications

  • Application: ELISA ; IHC ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Li et al. 2015. Mol Endocrinol. 29(1):40-52. PMID: 25394262.
  • Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes.
  • Simpson et al. 2014. J Clin Endocrinol Metab. 99(4):E615-24. PMID: 24438375.
  • Aberrant GDF9 expression and activation are associated with common human ovarian disorders.
  • Simpson et al. 2012. Endocrinology. 153(3):1301-10. PMID: 22234469.
  • Activation of latent human GDF9 by a single residue change (Gly 391 Arg) in the mature domain.
  • Mottershead et al. 2008. Mol Cell Endocrinol. 283(1-2):58-67. PMID: 18162287.
  • Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells.
  • Gilchrist et al. 2004. Biol Reprod. 71(3):732-9. PMID: 15128595.
  • Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.